TY - JOUR T1 - Methylation Analysis of the BMPR2 Gene Promoter Region in Patients With Pulmonary Arterial Hypertension JO - Archivos de Bronconeumología T2 - AU - Pousada,Guillermo AU - Baloira,Adolfo AU - Valverde,Diana SN - 15792129 M3 - 10.1016/j.arbr.2016.03.020 DO - 10.1016/j.arbr.2016.03.020 UR - https://www.archbronconeumol.org/en-methylation-analysis-bmpr2-gene-promoter-articulo-S157921291630026X AB - IntroductionPulmonary arterial hypertension is characterized by obstruction of the pulmonary arteries. The gene, mainly related to pathology, is the bone morphogenetic protein receptor type II (BMPR2). The aim of this study was to analyze the methylation pattern of the BMPR2 promoter region in patients and controls. MethodsWe used Methyl Primer Express® v.1.0 and MatInspector softwares to analyze this region. Genomic DNA obtained from the peripheral blood of patients and controls was modified with sodium bisulphite. Methylation was analyzed using methylation-specific PCR. DNA treated with CpG methyltransferase was used as a positive control for methylation and H1299 cell culture DNA was used as positive control for gene expression. ResultsWe identified a CpG island, which may have been methylated, in the BMPR2 promoter region, in addition to NIT-2 (global-acting regulatory protein), sex-determining region Y and heat shock factor transcription factor binding sites. We found no evidence of methylation in patients and controls. No methylated CpG sites were identified in H1299 cells expressing the BMPR2 gene. ConclusionsThe BMPR2 promoter region is the most suitable for study because of the high number of transcription factor binding sites that could alter gene function. No evidence of methylation was detected in this region in patients and controls. ER -